ADNCD
   
 
 
Select Mode of Action
Anti-diabetic mode of action: Glucose Transporter Type 4 activation
GLUT4 activators
S.No. Compound Reference Physicochemical Properties and Toxicity Risks
1 AndrographolideYu et al., 2003 Zhang et al., 2009 Properties and Risk Assessment
2 ApigeninHossain et al., 2014 Properties and Risk Assessment
3 ArecolineLing et al., 2014 Properties and Risk Assessment
4 Tormentic AcidWu et al., 2014 Properties and Risk Assessment
5 Caffeic acidJung et al., 2006 Huang and Shen, 2012 Properties and Risk Assessment
6 RutinKappel et al., 2013 Properties and Risk Assessment
7 AegelineGautam et al., 2015 Properties and Risk Assessment
8 NymphayolSubash-babu et al., 2015 Properties and Risk Assessment
9 CinnamaldehydeJuane et al., 2012 Properties and Risk Assessment
10 GentianineVaidya et al., 2012 Properties and Risk Assessment
11 Palmitic acidJing et al., 2015 Properties and Risk Assessment
12 AspalathinSon et al., 2013 Properties and Risk Assessment
13 Carnosic acidLipina and Hundal Properties and Risk Assessment
14 PalmatineSangeetha et al. 2013 Vasanthi and Kannan, 2012 Properties and Risk Assessment
15 Ginsenoside Rh2EI-Abhar and Schaalan, 2014 Properties and Risk Assessment
16 Methyl caffeateGandhi et al., 2011 Properties and Risk Assessment
17 MyricetinLiu et al., 2007 Properties and Risk Assessment
18 Ginsenoside Rb1Shang et al., 2008 Properties and Risk Assessment
19 Diallyl disulphideLiu et al., 2012 Properties and Risk Assessment
20 DiosgeninSato et al., 2013 Properties and Risk Assessment
21 6-GingerolChakraborty et al., 2012 Properties and Risk Assessment
22 NobiletinLee et al., 2010 Properties and Risk Assessment
23 Cyanidin-3-glucosideSasaki et al., 2007 Properties and Risk Assessment
24 Tannic acidLiu et al., 2005 Properties and Risk Assessment
25 LupeolLilly and Daisy, 2011 Properties and Risk Assessment
26 GallotanninKanaujia et al., 2010 Properties and Risk Assessment
27 KaempferolAlkhalidy et al., 2015 Properties and Risk Assessment